ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Agios Pharmaceuticals

Official 2024 U.S. DOL Form 5500 summary for Agios Pharmaceuticals (Agios Pharmaceuticals 401(k) Plan · EIN 26-0662915 · PN 001): $106.20M net assets, 491 active participants, and $7.81 per $10,000 (7.81 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorAgios Pharmaceuticals
Filing IdentifierAgios Pharmaceuticals 401(k) Plan · EIN 26-0662915 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$106.20M
Active Participants491
Direct Admin Fee Rate$7.81 per $10,000 (7.81 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI